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Effects of dietary protein and phosphorus restriction on the progression
of early renal failure. Three groups of patients with chronic renal failure
were studied. Group I comprised 25 patients with a mean serum
creatinine of 2.18 mg/dl and a mean arterial pressure of 117 mm Hg.
Group 2 had 20 patients with a mean serum creatinine of 4.24 mg/dl and
a mean arterial pressure of 119 mm Hg. All these patients were kept for
18 to 76 months on a diet containing about 40 kcal/kg, 0.6 g/kg of
protein, 700mg of phosphorus, and 1,000 to 1,500mg of calcium (orally
supplemented). Group 3 comprised 30 patients with a mean serum
creatinine of 2.28 mg/dl and a mean arterial pressure of 116 mm Hg.
They had followed no specific dietary regimen for 3 to 72 months, and
their dietary calorie, protein, phosphorus, and calcium intakes averaged
35 kcal/kg, 70 g, 900 mg, and 800 mg, respectively. The plots of
reciprocal creatinine against time gave slopes of —0.0008 and —0.0010
in patients in groups I and 2, and a slope of —0.020 in group 3 patients.
The slopes of both groups 1 and 2 were statistically different (analysis of
variance and "F" test, P < 0.01) from that of group 3. No evidence of
progressive protein and phosphorus depletion was observed in groups 1
and 2 patients. We conclude that a moderate dietary restriction of
protein and phosphorus is an acceptable and effective regimen for
delaying progression of functional deterioration in early renal failure.
Effet de Ia restriction protéique et phosphoree alimentaire sur Ia
progression de l'insuffisance rénale debutante. Trois groupes de malades
ayant une insuffisance rénale chronique ont été étudiés. Le groupe I
comprenait 25 malades ayant une créatinine sérique moyenne de 2,18
mg/dl et une pression artérielle moyenne de 117 mm Hg. Le groupe 2
comportait 20 malades ayant une créatinine sérique moyenne de 4,24
mg/dl et une pression artérielle moyenne de 119 mm Hg. Tous ces
malades ont été soumis pendant 18 a 76 mois a un régime contenant
environ 40 kcal/kg, 0,6 kg de proteines, 700 mg de phosphore, et 1000 a
1500 mg de calcium (par supplementation orale). Le groupe 3 compren-
ait 30 malades ayant une créatinine sérique moyenne de 2,28 mg/dl et
une pression artérielle moyenne de 116 mm Hg. Ils n'avaient pas suivi
de régime alimentaire spécifique pendant 3 a 72 mois, et leurs apports
alimentaires caloriques, protéiques, phosphorés et calciques étaient en
moyenne de 35 kcal/kg, 70 g, 900 mg, et 800 mg, respectivement. Les
courbes de créatinine en fonction du temps ont donne des pentes de
—0,0008 et de —0,0010 chez les malades des groupes I et 2, et une pente
de —0,020 chez ceux de groupe 3. Des pentes des groupes 1 et 2
différaient statistiquement (analyse de variance et test de 'F", P <
0,01) de ceux du groupe 3. II n'a pas été observe de preuve de depletion
progressive en protéines et en phosphore chez les malades des groupes
I et 2. Nous concluons qu'une restriction alimentaire modérée en
proteines et en phosphore est un régime acceptable et efficace pour
retarder Ia progression de Ia détérioration fonctionnelle au cours de
l'insuffisance rénale précoce.
In the last few years, accumulating experimental evidence
reports that dietary protein and phosphorus restriction may
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have beneficial effects on the structure and function of the
remnant kidney in animals with surgically induced reduction of
renal mass.
In rats, dietary phosphorus restriction has prevented hyper-
phosphatemia, increased phosphaturia per nephron, parenchy-
ma! calcification, fibrosis in the remnant kidney, functional
deterioration, and death in uremia [1, 21. In addition, low-
phosphate diets may prevent severe glomerular and tubular-
interstitial damage and functional deterioration in rats with
established nephrotoxic serum nephritis [31.
On the other hand, restriction of dietary protein intake has
been effective in preventing both hyperfiltration and histologic
lesions in remnant glomeruli of rats with reduced renal mass F41
as well as functional renal deterioration in the same experimen-
tal model [5—71.
The clinical applicability of these experimental results is still
under evaluation. There is no agreement on what stage of
chronic renal failure dietary protein restriction should be start-
ed and the degree to which protein and phosphorus should be
limited. We report in this study the results obtained in the last
few years, during which a dietary protocol—originally intended
for preventing renal osteodystrophy [8, 91—was followed spe-
cifically for delaying progression of chronic renal failure in two
groups of patients with different degrees of functional deteriora-
tion. A comparison has been made with a third group of
patients, whose evolution has been assumed to represent the
clinical course of chronic renal failure when dietary protein and
phosphorus restriction were not prescribed.
Methods
Three groups of patients with chronic renal failure were
studied:
Group 1. This group comprised 25 patients, aged 25 to 68
years, with serum creatinine concentrations of 1.55 to 2.70 mg/
dl (mean, 2.18). The underlying renal disease was established
by means of renal biopsy in eight patients and by history,
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clinical, and radiological data in 17 patients. Eight patients had
chronic pyelonephritis; seven, chronic glomerulonephritis; two,
benign nephrosclerosis; one, renal tuberculosis; one, diabetic
renal disease; one, Alport syndrome; and in five of them the
underlying renal disease was unknown. Their mean arterial
pressure was 117 mm Hg, and 60% of them were hypertensive.
All patients were kept for 28 to 76 months (mean, 48.2) on a diet
containing about 40 kcal/kg, 0.6 glkg of protein (75% of which
had high biological value), 600 to 750 mg of phosphorus, about
75 mEq of sodium and chloride, and 1,000 to 1,500 mg of
calcium (orally supplemented). Additional treatment with vita-
min D or its analogues was given for only short periods to some
patients, and conventional antihypertensives (alpha-methyldo-
pa, clonidine, propranolol) or allopurinol was only prescribed
when needed.
Fig. 1. The follow-up of group 1 patients with
chronic renal failure on a protein-restricted
diet. The dotted line represents the doubling of
initial mean values of serum creatinine in the 25
patients.
Fig. 2. The follow-up of the 20 patients in group
2 with chronic renal failure on a protein-re-
stricted diet.
Group 2. This group comprised 20 patients, aged 35 to 68
years, with serum creatinines of 2.90 to 5,40 mg/dl (mean, 4.2).
The underlying renal diseases, established by means of renal
biopsy in five patients and by history, clinical, and radiological
data in the remaining 15, were chronic pyelonephritis in five
patients, polycystic renal disease in five, chronic glomerulone-
phritis in four, diabetic renal disease in two, and were unknown
in four patients. Their mean arterial pressure was 119 mm Hg,
and 80% of them were hypertensive. All patients were kept for
18 to 76 months (mean, 42.3) on the same diet as those in group
1. The extent to which patients in groups I and 2 followed their
prescribed diets was checked carefully by the members of the
staff by means of the following procedures every 2 to 3 months:
(1) dietary interviews with each patient and those members of
the family who were taking care of food preparation. Written
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Fig. 3. The follow-up of patients in group 3.
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dietary diaries at 2-month intervals also were obtained from
each patient; (2) control of blood urea nitrogen, simultaneously
to that of creatinine; (3) control of urine phosphate and urea
excretions. Additional treatment with vitamin D analogues was
only given for short periods to some patients, and conventional
antihypertensive drugs or allopurinol was only prescribed when
needed.
Group 3. This group had 30 patients, aged 13 to 73 years, with
serum creatinines of 1.60 to 4.70 mg/dl (mean, 2.28). The
underlying renal diseases, established by means of renal biopsy
in 11 patients and by history, clinical, and radiological data in
the remaining 19, were chronic glomerulonephritis in 11 pa-
tients, chronic pyelonephritis in 6, polycystic renal disease in 5,
benign nephrosclerosis in 2, diabetic renal disease in 1, and in 5
patients the disease was unknown. Their mean arterial pressure
was 116 mm Hg, and 50% were hypertensive. All these patients
were referred to our units by other colleagues. Since the
discovery of renal failure in the patients, no attempt to control
serum phosphorus and calcium levels by means of dietary
restriction, calcium supplementation, or vitamin D administra-
tion had been done for 3 to 72 months (mean, 23.4). A good
control of blood pressure and serum uric acid levels, however,
had been obtained in nearly all patients with conventional
antihypertensives or allopurinol. A careful survey of dietary
intakes was done in all patients and in those members of their
family who prepared the food. The estimated dietary calorie,
protein, phosphorus, sodium, and calcium intakes averaged 35
kcallkg, 70 g, 900 mg, 70 mEq, and 800 mg, respectively. After
the first visit in our units, group 3 patients were given the same
diet as those in groups 1 and 2, and the prospective follow-up
then ranged from 1 month to 2 years.
Serum concentrations of total protein, albumin, urea nitro-
gen, creatinine, phosphate, and calcium, and urine phosphate
and urea nitrogen were determined with a Technicon Autoana-
lyzer. Skeletal muscle biopsy specimens were taken from
muscle quadriceps femoris according to the technique of Berg-
strom [101. The fat-free solid tissue was chosen as the base of
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Fig. 4. Relationship of the reciprocal of serum-creatinine concentra-
tion, plotted against time, in the three groups of patients. Statistical
comparison (analysis of variance and "F" test): Group I vs. group 3, F
= 17.2, P <0.01; group 2 vs. group 3, F 11.9, P < 0.01.
reference for the inorganic phosphate and protein nitrogen
contents [111. The evaluation of the rate of functional renal
deterioration was calculated using linear regression analysis
from the relationship between time and the reciprocal of serum-
creatinine concentration [12, 131. In this analysis, the slope
represents the fraction of initial renal function lost per month (in
milligrams per deciliter), assuming that serum creatinine before
the onset of renal failure was 1 mg/dl.
For statistical comparison of the slopes in the three groups of
patients, the methods of analysis of variance and the "F" test
were used.
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Fig. 5. The regression lines for the changes in
renal function before (closed circles) and after
(stars) dietary treatment in eight patients from
group 3. Difference between the mean values of
the slopes equals: F = 6.57, P < 0.01.
Fig. 6. Mean values of serum phosphate significantly higher in patients
in group 3 than in those in groups I and 2. Symbols: •, group 1; 0,
group 2; A, group 3; , P < 0.005; , normal range.
Results
The follow-up of group 1 showed remarkably stable renal
function in most patients. In only three of them was there
evidence of significant deterioration of renal function, ex-
pressed by a rise of serum creatinine above the doubling of
initial mean values (Fig. 1). In group 2, two patients had to start
hemodialysis or peritoneal dialysis during the follow-up (Fig. 2).
In group 3, about 40% of the patients had a rise of their serum-
creatinine concentration above the doubling of initial mean
values during the clinical course of their disease before pre-
scription of the diet (Fig. 3). Since, in most of our patients, the
relation of the reciprocal of serum-creatinine concentration
plotted against time was linear, the data were analyzed by linear
regression. We obtained slopes of —0.0008 and —0.0010 in the
two groups of patients on the protein-restricted diet, and a slope
of —0.020 in that of patients on a free diet (Fig. 4). The
differences between the slopes in patients in groups I and 2
versus that in patients in group 3 are statistically significant:
group 1 vs. group 3, F = 17.2, P < 0.01; group 2 vs. group 3, F
= 11.9, P < 0.01. After the diet was prescribed, we obtained a
follow-up sufficient to make a reliable comparison with the pre-
treatment period in eight patients, whose regression lines for
the changes in renal function before and after the treatment are
reported in Figure 5. The difference between the mean values of
the slopes before (—0.0132) and after (—0.0013) the dietary
treatment is statistically significant (F = 6.57, P < 0.01).
A good control of serum calcium and phosphorus concentra-
tions was obtained regularly in both groups of patients on the
protein-restricted diet, whereas the mean values of serum
phosphate were significantly higher in those without dietary
treatment (Fig. 6). The serum concentrations of total protein
and albumin did not change significantly during the treatment.
The serum concentrations of urea nitrogen were always found
to be adequate to those of serum creatinine and hence to reflect
the prescribed protein intake at all levels of renal function. The
relative figures were as follows: BUN 25.8 4.5 mgldl (mean
SD) at S. of 2.0 mg/dl; BUN 41.0 10.0 at S of 3.0; BUN 44.0
9.9 at Scr of 4.0; BUN 60.0 12 at Scr of 5.0; BUN 69.0
10.0 at Scr of 6.0 mg/dl.
The urinary excretion of phosphate, whether expressed per
24 hr or factored per deciliter of GFR (creatinine clearance),
was significantly smaller in patients in group I than in those in
group 3, at comparable levels of renal function (Table 1). A
biochemical analysis of muscle tissue was available in 20
patients and showed normal mean values of phosphate and cell
protein contents, without correlation to the duration of dietary
treatment (Fig. 7).
Discussion
During the first 5 years (1970 to 1974) of administration of
protein-restricted diets to prevent renal osteodystrophy, we did
not look specifically at the survival of renal function in our
patients. However, a retrospective analysis of 18 patients with
chronic renal failure of varying etiology, followed for 5 to 13
years, showed that their serum creatinine concentrations had
increased from the mean values of 4.3 to only 8.2 mg/dl over a
mean period of 7 years, during which good control of the serum
concentrations of calcium and phosphate also was obtained
114]. Our present data suggest that dietary protein restriction,
with emphasis on control of serum calcium and phosphate, is
effective in preventing secondary hyperparathyroidism and
bone disease [19], as well as in delaying the progression of
chronic renal failure.
In our opinion, the degree of functional renal deterioration is
critical in modulating the effects of dietary protein and phospho-
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Urinary P04
Average P04 per deciliter
intake Urinary P04 of GFR
mg124 hr mg/24 hr C.
Normal subjects (41) 900 594
201
495
179
Patients with chronic 900 558 1992
renal failure on free 160 440
diet (group 3) (30)
Patients with chronic 650 377b 1450L
renal failure on diet 109 375
(group 1) (25)
a The values are expressed as mean sD. The numbers in parenthe-
ses refer to the number of patients.
P < 0.01 (Student's t test) when compared with group 3.
rus restriction; this therapeutic regimen produces better results
in patients with only a moderate loss of renal function than in
those with more advanced renal failure. Therefore, in agree-
ment with Giordano [151, we prefer to restrict protein and
phosphorus intakes early in the course of renal failure rather
than in uremia, when the efficiency of protein utilization is
reduced, tissue protein synthesis is diminished, catabolism is
increased greatly, and signs of toxicity, including nausea and
anorexia, are usually present [161.
For these reasons, our data are not comparable with those
obtained by others [17, 181 in patients with advanced renal
failure treated with low-protein diets supplemented with essen-
tial aminoacids and keto-analogues for a limited time. Further-
more, since only two of our patients began dialysis during the
follow-up, we were unable to choose the deterioration time,
that is, the value of elapsed survival time from early to endstage
renal failure [15], as a measurable index in our population.
Some years ago, two groups of investigators showed that the
average rate of decrease in reciprocal creatinine (in deciliters
per milligram per month) was a reliable quantitative measure of
the rate of progression of renal failure, regardless of the
underlying renal disease [12, 13]. Since the relation of the
reciprocal of serum creatinine concentration plotted against
time was linear in most of our patients, the data were analyzed
by linear regression. In patients with early renal failure on a
protein-restricted diet (group 1), the average rate of decrease in
reciprocal creatinine was nearly ten times lower than that
observed by Mitch et al [12] and 20 to 40 times lower than those
found by others [13, 19, 201 in patients who were not treated
with dietary protein restriction.
Our results seem to be at variance with those reported in a
recent paper [21] which states that a decrease in serum phos-
phate concentration, mainly obtained by administering large
amounts of aluminum hydroxide, failed to significantly affect
the rate of progression in a group of patients with moderate or
advanced renal failure treated for a mean period of 10 months.
Unfortunately, the authors gave no information on dietary
protein, phosphate, calcium, and calorie intakes and on control
of blood pressure in their patients. On the other hand, these
apparently different data stress once again the importance of an
earlier dietary protein and phosphorus restriction in patients
with chronic renal failure.
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Fig. 7. Mean values of muscle inorganic phosphate and cell protein
contents normal in 20 patients on a low-protein diet. There is no
correlation to the duration of dietary treatment. Abbreviations: ASPN,
alkali-soluble protein nitrogen; FFS, fat-free solid tissue. Normal range
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The role of protein and phosphorus intakes has not been
definitely separated as yet. The reduction in nitrogen load, the
prevention of hyperfiltration and histologic lesions in surviving
nephrons, the prevention of secondary hyperparathyroidism,
the maintenance of a normal calcium times phosphate product,
and the reduced phosphaturia per nephron might all contribute
to the effectiveness of dietary treatment in patients with early
renal failure. Since in our diet both the contents of protein and
phosphorus were reduced in a comparable manner, the results
of our study do not allow any conclusion on the relative role of
protein or phosphorus restriction.
The patients' adherence to our diet has been very good, as is
to be expected in a country where the average protein intake
only recently has reached about 70 g/day.
Our results on tissue composition showed that dietary thera-
py, when properly applied, does not produce progressive
protein and phosphorus depletion. On the other hand, metabol-
ic studies of diets with a very similar composition showed that
patients usually achieve neutral or positive nitrogen balance
[221.
In conclusion, we believe that moderate dietary restriction of
protein and phosphorus should begin early in patients with
chronic renal failure to prevent renal osteodystrophy and to
slow the progression of functional deterioration. Our dietary
regimen is acceptable, and the maintenance of normal electro-
lyte and uric acid balances and blood pressure is obtained
readily with conventional drugs (when needed).
Clearly, however, further studies along these lines are indi-
cated before the conclusion can be reached that dietary man-
agement is a counteraction to the progression of chronic renal
disease.
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